The original success of Sildenafil undeniably reshaped the drug landscape, but betting in companies primarily reliant on unbranded versions presents a complex picture. Although early profits were impressive, the end of patents and the rise of less expensive alternatives have eroded the customer base. Consequently, a thorough assessment of ongoin… Read More